Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1987-1995. doi: 10.1167/iovs.18-26333.
To investigate the potential neuroprotective effect of sildenafil on the ocular circulation in mice with/without optic nerve crush (ONC).
Male adult mice (n = 63) were treated with intravitreal (IVT) sildenafil 24 μg/3 μL, intraperitoneal (IP) sildenafil 24 μg/300 μL, or IP saline immediately before right ONC induction (ONC group). A second group (n = 123) received the same treatments without ONC induction (naïve group). Evaluations included fluorescein angiography (naïve group; day 0), molecular studies (days 1 and 3), and retinal and optic nerve histology (day 21).
Maximal retinal vessel dilatation and increased choroidal effusion were detected within 30 minutes of sildenafil injection. In the ONC group, moderate retinal ganglion cell (RGC) loss was noted at 21 days. However, molecular studies showed increased stress induced gene expression (IP superoxide dismutase [SOD]-1: 3.1-fold; heme oxygenase [HO]-1: 5.8-fold; IVT SOD-1: 1.47-fold), proapoptotic gene expression (IP BAX/B-cell lymphoma [BCL]-2 10.8-/2.3-fold), and glial gene expression (IP glial fibrillary acidic protein [GFAP]: 2.8- and myelin basic protein [MBP]: 2.5-fold). In the naïve group, IVT sildenafil was not associated with RGC loss or optic nerve stroke on histology, although in two samples, molecular parameters were compatible with stroke, showing increased gene expression of HO-1 (3.8-fold) and BCL-2 (2.5-fold). In the IP sildenafil subgroup, optic neuropathy was observed in 6/120 optic nerves, including 3 cyan fluorescence protein (CFP)-Thy-1 mice. Levels of antiapoptosis and anti-ischemia genes were decreased (<0.5-fold) except for three outliers.
Sildenafil affects retinal and choroidal perfusion in mice. When injected immediately before ONC, molecular parameters showed a preconditioning neuroprotective effect while histologic studies did not. In the absence of ONC, it is associated with neuropathy, possibly dose-dependent.
研究西地那非对视神经挤压(ONC)小鼠眼循环的潜在神经保护作用。
雄性成年小鼠(n = 63)分别玻璃体腔内(IVT)注射西地那非 24 μg/3 μL、腹腔内(IP)注射西地那非 24 μg/300 μL 或 IP 生理盐水,然后立即诱导右侧 ONC(ONC 组)。第二组(n = 123)在不诱导 ONC 的情况下接受相同的治疗(未损伤组)。评估包括荧光素血管造影(未损伤组;第 0 天)、分子研究(第 1 天和第 3 天)和视网膜及视神经组织学检查(第 21 天)。
西地那非注射后 30 分钟内可检测到最大视网膜血管扩张和脉络膜渗出增加。在 ONC 组,第 21 天观察到中度视网膜神经节细胞(RGC)丢失。然而,分子研究显示应激诱导基因表达增加(IP 超氧化物歧化酶[SOD]-1:3.1 倍;血红素加氧酶[HO]-1:5.8 倍;IVT SOD-1:1.47 倍)、促凋亡基因表达(IP BAX/ B 细胞淋巴瘤[BCL]-2 10.8/2.3 倍)和神经胶质基因表达(IP 神经胶质纤维酸性蛋白[GFAP]:2.8 倍和髓鞘碱性蛋白[MBP]:2.5 倍)。在未损伤组中,IVT 西地那非在组织学上与 RGC 丢失或视神经卒中无关,但在两个样本中,分子参数与卒中相符,HO-1(3.8 倍)和 BCL-2(2.5 倍)的基因表达增加。在 IP 西地那非亚组中,6/120 根视神经中观察到视神经病变,包括 3 只 CFP-Thy-1 小鼠。除 3 例外,抗凋亡和抗缺血基因的水平降低(<0.5 倍)。
西地那非影响小鼠视网膜和脉络膜灌注。当在 ONC 前立即注射时,分子参数显示出预处理的神经保护作用,而组织学研究没有。在没有 ONC 的情况下,它与神经病变有关,可能与剂量有关。